Chiesi farmaceutici s.p.a. to acquire amryt pharma plc

Chiesi farmaceutici s.p.a. to acquire amryt pharma plc. all cash acquisition at us$14.50 per ads, plus contingent value rights of up to an additional us$2.50 per ads based on certain filsuvez® milestones being achieved

AMYT Ratings Summary

AMYT Quant Ranking